nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study
|
Anjana, Ranjit Mohan |
|
|
10 |
6 |
p. 430-441 |
artikel |
2 |
Add-on value of tirzepatide versus semaglutide
|
Scheen, André J |
|
|
10 |
6 |
p. 377-378 |
artikel |
3 |
Decision making in differences of sex development/intersex care in the USA: bridging advocacy and family-centred care
|
Sandberg, David E |
|
|
10 |
6 |
p. 381-383 |
artikel |
4 |
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
|
Gastaldelli, Amalia |
|
|
10 |
6 |
p. 393-406 |
artikel |
5 |
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
|
Heise, Tim |
|
|
10 |
6 |
p. 418-429 |
artikel |
6 |
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
|
Battelino, Tadej |
|
|
10 |
6 |
p. 407-417 |
artikel |
7 |
Hot topics on insulin access: the issue of thermostability
|
Burki, Talha |
|
|
10 |
6 |
p. 389-390 |
artikel |
8 |
Management of menopause: a view towards prevention
|
Lobo, Roger A |
|
|
10 |
6 |
p. 457-470 |
artikel |
9 |
Menopause: a cardiometabolic transition
|
Nappi, Rossella E |
|
|
10 |
6 |
p. 442-456 |
artikel |
10 |
Menopause: a turning point for women's health
|
The Lancet Diabetes & Endocrinology, |
|
|
10 |
6 |
p. 373 |
artikel |
11 |
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence
|
Chabre, Olivier |
|
|
10 |
6 |
p. 384-385 |
artikel |
12 |
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence – Authors' reply
|
Fleseriu, Maria |
|
|
10 |
6 |
p. 385-387 |
artikel |
13 |
Postsurgical radioiodine ablation in low-risk differentiated thyroid cancer
|
Pacini, Furio |
|
|
10 |
6 |
p. 379-381 |
artikel |
14 |
Singapore's “War on Diabetes”
|
Bee, Yong Mong |
|
|
10 |
6 |
p. 391-392 |
artikel |
15 |
SURPASSing the current dogma: is our framework shifting?
|
Malkani, Natasha P |
|
|
10 |
6 |
p. 375-376 |
artikel |
16 |
The ABC targets of diabetes in India
|
Manne-Goehler, Jennifer |
|
|
10 |
6 |
p. 378-379 |
artikel |
17 |
Tirzepatide adds hepatoprotection to its armoury
|
Targher, Giovanni |
|
|
10 |
6 |
p. 374-375 |
artikel |
18 |
War in Ukraine ups demand for iodine pills
|
Burki, Talha |
|
|
10 |
6 |
p. 388 |
artikel |